Evolution of cardiovascular risk factors, analytical markers and functional capacity. Are the benefits of phase II of the cardiac rehabilitation program maintained in phase III?

11 April 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Mrs Belen Garcia Magallon

Guadalajara University Hospital, Guadalajara (Spain)

30 More presentations in this session

Presentation thumbnail

Application for cardiac self-Improvement(ANSIM), a randomized controlled trial: 9-month clinical outcome

Doctor J. Kim (Seoul, KR)

Presentation thumbnail

Do women with cardiovascular disease respond differently to aerobic interval training? Exploring the interaction between sex and exercise modality on psychological and cardiomtabolic health

Doctor T. Terada (Nottingham, GB)

Presentation thumbnail

A randomized trial of an exercise maintenance intervention after cardiac rehabilitation

Doctor R. Reid (Ottawa, CA)

Abstract Slides

Presentation thumbnail

Effects of a community-based lifestyle intervention in older patients with coronary artery disease: results from the RESPONSE-2 trial

Miss P. Jepma (Amsterdam, NL)

Presentation thumbnail

Admission cardiac troponin T improves risk stratification of patients with ST elevation myocardial infarction

Doctor J. Coelho Lima Junior (Cambridge, GB)

Access the full session

Session thumbnail

Poster Session 2 - Risk Factors and Prevention - Secondary Prevention

The Event

EuroPrevent 2019

11 April - 13 April 2019

You may be interested in

Congress Presentation

Making personalised prevention everyone's business

Congress Presentation

Should we intervene early in patients with asymptomatic aortic stenosis?

Congress Presentation

Cardiovascular prevention in older adults

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources